That's more than vegans and vegetarians combined. The report tracks how users eat out, with beer down to 42% of drinking occasions and smaller portions in demand.
Recap by typeshit. Full story at FoodNavigator.com.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
He cites FDA counts of 990 adverse event reports tied to compounded semaglutide and over 730 for compounded tirzepatide, and warns about research-use-only sellers.
Trials show no overall rise in cancer with GLP-1 drugs, OncoDaily says, but thyroid cancer is still a watch point and long-term effects remain unclear.
Loading…